Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
Status PubMed-not-MEDLINE Language English Country United States Media electronic-ecollection
Document type Journal Article
PubMed
35449513
PubMed Central
PMC9017568
DOI
10.1155/2022/7206713
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
OBJECTIVE: Pituitary adenoma surgery has evolved rapidly in recent decades. This study aims to determine current practice across a wide range of European neurosurgical centers. METHODS: A list of eligible departments performing pituitary adenoma surgery was created. The survey consisted of 58 questions. For analysis, the departments were divided into four subgroups: academic/nonacademic, high-volume/low-volume, "mainly endoscopic/mainly microscopic practice," and geographical regions. RESULTS: Data from 254 departments from 34 countries were obtained. In 108 centers (42.5%), <30 pituitary adenomas were operated per year. Twenty (7.9%) centers performed >100 adenoma surgeries per year. Number of neurosurgeons performing endonasal surgeries are as follows: 1 in 24.9% of centers and 2 in 49.8% of centers. All residents assisted endonasal surgeries in 126 centers (49.8%). In 28 centers (21.1%), all residents performed endonasal surgery under supervision during residency. In 141 centers (56.8%), the endoscopic approach was used in >90% of the surgeries. Regular pituitary board (either weekly or once a month) meetings were held in 147 centers (56.3%). Nonfunctioning adenomas represent >70% of pituitary caseload in 149 centers (58.7%). CONCLUSIONS: In our survey, most centers perform less than 100 surgeries for pituitary adenomas. In most centers, pituitary surgeries are performed by one or two neurosurgeons. Residents have a limited exposure to this type of surgery, and the formal pituitary board is not a standard. Nonfunctioning adenomas make up most of surgically treated adenomas. This study can serve as a benchmark for further analyses of pituitary adenoma centers in Europe.
1st Department of Neurosurgery Aristotle University of Thessaloniki Thessaloniki Greece
Department of Neuroscience Rita Levi Montalcini Neurosurgery Unit University of Turin Turin Italy
Department of Neurosurgery Johannes Gutenberg Universitat Mainz Mainz Germany
Department of Neurosurgery Kings College London UK
Department of Neurosurgery Lariboisiere University Hospital Paris France
Department of Neurosurgery Radboud University Medical Centre Nijmegen Nijmegen Netherlands
Neurosurgery Department University Hospital Donostia San Sebastian Donostia Spain
See more in PubMed
Murad M. H., Fernández-Balsells M. M., Barwise A., et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clinical Endocrinology . 2010;73(6):777–791. doi: 10.1111/j.1365-2265.2010.03875.x. PubMed DOI
Molitch M. E. Diagnosis and treatment of pituitary adenomas. JAMA . 2017;317(5):516–524. doi: 10.1001/jama.2016.19699. PubMed DOI
McLaughlin N., Carrau R., Kelly D., Prevedello D., Kassam A. Teamwork in skull base surgery: an avenue for improvement in patient care. Surgical Neurology International . 2013;4(1):p. 36. doi: 10.4103/2152-7806.109527. PubMed DOI PMC
United Nations Statistics Division–Geographic Regions. 1999.
Solari D., Zenga F., Angileri F. F., et al. A survey on pituitary surgery in Italy. World Neurosurg . 2019;123:440–449. doi: 10.1016/j.wneu.2018.11.186. PubMed DOI
Nachtigall L. B., Karavitaki N., Kiseljak-Vassiliades K, et al. Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey. Pituitary . 2019;22(1):37–45. doi: 10.1007/s11102-018-0924-0. PubMed DOI PMC
de Divitiis E., Laws E. R., Giani U., Iuliano S. L., de Divitiis O., Apuzzo M. L. The current status of endoscopy in transsphenoidal surgery: an international survey. World Neurosurg . 2015;83(4):447–54. doi: 10.1016/j.wneu.2014.12.029. PubMed DOI
Casanueva F. F., Barkan A. L., Buchfelder M., et al. On behalf of the pituitary society: expert group on pituitary tumors: criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary . 2017;20(5):489–498. doi: 10.1007/s11102-017-0838-2. PubMed DOI PMC
McLaughlin N., Laws E. R., Oyesiku N. M., Katznelson L., Kelly D. F. Pituitary Centers of Excellence. Neurosurgery . 2012;71(5):916–924. doi: 10.1227/NEU.0b013e31826d5d06. PubMed DOI
Bates P. R., Carson M. N., Trainer P. J., Wass J. A. H., UK National Acromegaly Register Study Group (UKAR-2) Wide variation in surgical outcomes for acromegaly in the UK. Clinical Endocrinology . 2008;68(1):136–142. doi: 10.1111/j.1365-2265.2007.03012.x. PubMed DOI
Barker F. G., Klibanski A., Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. Journal of Clinical Endocrinology & Metabolism . 2003;88(10):4709–4719. doi: 10.1210/jc.2003-030461. PubMed DOI
Ciric I., Ragin A., Baumgartner C., Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery . 1997;40(2):225–237. doi: 10.1097/00006123-199702000-00001. PubMed DOI
Wheless S. A., McKinney K. A., Zanation A. M. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryngology-Head and Neck Surgery . 2010;143(5):650–654. doi: 10.1016/j.otohns.2010.07.020. PubMed DOI PMC
Molitch M. E. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinology and Metabolism Clinics of North America . 2008;37(1):151–171. doi: 10.1016/j.ecl.2007.10.011. PubMed DOI
Reincke M., Allolio B., Saeger W., Menzel J., Winkelmann W. The ‘incidentaloma’ of the pituitary gland. JAMA . 1990;263(20):2772–2776. doi: 10.1001/jama.1990.03440200076026. PubMed DOI
Dekkers O. M., Pereira A. M., Romijn J. A. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. Journal of Clinical Endocrinology & Metabolism . 2008;93(10):3717–3726. doi: 10.1210/jc.2008-0643. PubMed DOI
Fatemi N., Dusick J. R., Mattozo C., et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery . 2008;63(4):709–719. doi: 10.1227/01.NEU.0000325725.77132.90. PubMed DOI
Grand’Maison S., Weber F., Bédard M.-J., Mahone M., Godbout A. Pituitary apoplexy in pregnancy: a case series and literature review. Obstetric Medicine . 2015;8(4):177–183. doi: 10.1177/1753495X15598917. PubMed DOI PMC
Iglesias P., Rodríguez Berrocal V., Díez J. J. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine . 2018;61(3):407–421. doi: 10.1007/s12020-018-1645-x. PubMed DOI
Chabot J. D., Chakraborty S., Imbarrato G., Dehdashti A. R. Evaluation of outcomes after endoscopic endonasal surgery for large and giant pituitary macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurgery . 2015;84(4):978–988. doi: 10.1016/j.wneu.2015.06.007. PubMed DOI
D’Ambrosio A. L., Syed O. N., Grobelny B. T., Freda P. U., Wardlaw S., Bruce J. N. Simultaneous above and below approach to giant pituitary adenomas: surgical strategies and long-term follow-up. Pituitary . 2009;12(3):217–225. doi: 10.1007/s11102-009-0171-5. PubMed DOI PMC
Kuga D., Toda M., Ozawa H., Ogawa K., Yoshida K. Endoscopic endonasal approach combined with a simultaneous transcranial approach for giant pituitary tumors. World Neurosurgery . 2019;121:173–179. doi: 10.1016/j.wneu.2018.10.047. PubMed DOI
Yamada E., Akutsu H., Kino H., et al. Combined simultaneous endoscopic endonasal and microscopic transventricular surgery using a port retractor system for giant pituitary adenoma: a technical case report. Surgical Neurology International . 2021;12(12):p. 90. doi: 10.25259/SNI_826_2020. PubMed DOI PMC
Even-Zohar N., Greenman Y. Management of NFAs: medical treatment. Pituitary . 2018;21(2):168–175. doi: 10.1007/s11102-018-0865-7. PubMed DOI
Sheehan J., Lee C.-C., Bodach M. E., et al. Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas. Neurosurgery . 2016;79(4):E539–E540. doi: 10.1227/NEU.0000000000001385. PubMed DOI
Younus I., Gerges M. M., Uribe-Cardenas R., et al. How long is the tail end of the learning curve? results from 1000 consecutive endoscopic endonasal skull base cases following the initial 200 cases. Journal of Neurosurgery . 2020;7:1–11. doi: 10.3171/2019.12.JNS192600. PubMed DOI
